![]() |
Genentech Provides Update On Avastin For Metastatic Breast Cancer Following Reviews I
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), confirmed that following the reviews of AvastinĀ® (bevacizumab) in metastatic breast cancer by the European Medicines Agency (EMA) and the U.S...
More... |
| All times are GMT -7. The time now is 07:25 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021